Professor, Surgery, University of Minnesota Medical School
General Surgery
Dr. Arthur J. Matas, MD
|
|
Give Review
Arthur J. Matas is an expert in the field of General Surgery. He received awards:"America's Top Doctors", "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Dr. Arthur J. Matas is also published. He has 91 publications published. The lastest publication: "Renal Function Profile in White Kidney Donors: The First 4 Decades.' Dr. Arthur J. Matas is registered with Medicare and accepts Medicare payments.
Publications
- Renal Function Profile in White Kidney Donors: The First 4 Decades.
- Outcomes of Kidney Retransplantation in Recipients with Prior Post-Transplant Lymphoproliferative Disorder.
- Genomewide Association Study of Tacrolimus Concentrations in African American Kidney Transplant Recipients Identifies Multiple CYP3A5 Alleles.
- The impact of donor viral replication at transplant on recipient infections posttransplant: a prospective study.
- Daily fluid intake and outcomes in kidney recipients: post hoc Analysis from the randomized ABCAN trial.
- OPTN/SRTR 2013 Annual Data Report: kidney.
- Through a glass darkly: seeking clarity in preventing late kidney transplant failure.
- Valganciclovir Administration to Kidney Donors to Reduce the Burden of Cytomegalovirus and Epstein-Barr Virus Transmission During Transplantation.
- Quality of life in elderly kidney transplant recipients.
- Kidney donors at increased risk? Additional studies are needed.
- Reassessing Medical Risk in Living Kidney Donors.
- A regulated system of incentives for living kidney donation: it is time for opposing groups to have a meaningful dialogue!
- Who pleads for the majority?
- Comparison of Cystatin C and Creatinine-Based Equations for GFR Estimation After Living Kidney Donation.
- Medical outcomes of adolescent live kidney donors.
- Transplantation: Increased ESRD and mortality risk for kidney donors?
- The Role of Procurement Biopsies in Acceptance Decisions for Kidneys Retrieved for Transplant.
- Low birthweight and risk of albuminuria in living kidney donors.
- Uric Acid and Allograft Loss From Interstitial Fibrosis/Tubular Atrophy: Post Hoc Analysis From the Angiotensin II Blockade in Chronic Allograft Nephropathy Trial.
- Telomere length of recipients and living kidney donors and chronic graft dysfunction in kidney transplants.
- Diagnosis and management of antibody-mediated rejection: current status and novel approaches.
- Calcineurin inhibitors in HLA-identical living related donor kidney transplantation.
- OPTN/SRTR 2012 Annual Data Report: Kidney.
- Tolerance--Is It Worth It?
- Predictors of Graft Failure and Death in Elderly Kidney Transplant Recipients.
- Health-Related Quality of Life in Kidney Donors From the Last Five Decades: Results From the RELIVE Study.
- The renin-aldosterone axis in kidney transplant recipients and its association with allograft function and structure.
- The Unjustified Classification of Kidney Donors as Patients with CKD: Critique and Recommendations.
- Tacrolimus trough levels after month 3 as a predictor of acute rejection following kidney transplantation: a lesson learned from DeKAF Genomics.
- Antihypertensive pharmacotherapy and long-term outcomes in pediatric kidney transplantation.
- A Composite Risk Model for Predicting Technical Failure in Pancreas Transplantation.
- The impact of C4d and microVascular inflammation before we knew them.
- Demographic, metabolic, and blood pressure characteristics of living kidney donors spanning five decades.
- Prospective Randomized Trial of Maintenance Immunosuppression With Rapid Discontinuation of Prednisone in Adult Kidney Transplantation.
- Angiotensin II Blockade in Kidney Transplant Recipients.
- Inflammation in the setting of chronic allograft dysfunction post-kidney transplant: phenotype and genotype.
- OPTN/SRTR 2011 Annual Data Report: kidney.
- Kidney, pancreas and liver allocation and distribution in the United States.
- Donor-specific human leukocyte antigen antibodies and late graft fibrosis after pediatric liver transplantation: Time-associated variables or cause and effect?
- Graft loss due to recurrent Disease in pediatric kidney transplant recipients on a rapid prednisone discontinuation protocol.
- Donor polymorphisms of TLR4 associated with graft failure in liver transplant recipients.
- Lower Calcineurin Inhibitor Doses in Older Compared to Younger Kidney Transplant Recipients Yield Similar Troughs.
- Selection of controls in kidney donor outcome studies: an admirable effort.
- A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants.
- Outcome of living kidney donors left with multiple renal arteries.
- Validation of genetic variants associated with early acute rejection in kidney allograft transplantation.
- Consideration of Donor Age and Human Leukocyte Antigen Matching in the Setting of Multiple Potential Living Kidney Donors.
- Recurrent Glomerulonephritis Under Rapid Discontinuation of Steroids.
- Chronic progressive calcineurin nephrotoxicity: an overstated concept.
- Media appeals by pediatric patients for living donors and the impact on a transplant center.
- Optimal cutoff point for immunoperoxidase detection of C4d in the renal allograft: results from a multicenter study.
- Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure.
- Steroid minimization for sirolimus-treated renal transplant recipients.
- Steroid-free maintenance immunosuppression and ABO-incompatible transplantation.
- Urinary Peptide patterns in native kidneys and kidney allografts.
- Appraisal of GFR-estimating equations following kidney donation.
- Pregnancy outcomes after kidney donation.
- Does statin usage reduce the risk of corticosteroid-related osteonecrosis in renal transplant population?
- Long-term consequences of kidney donation.
- Kidney transplant half-life (t[1/2]) after rapid discontinuation of prednisone.
- Transplant center regulations--a mixed blessing? An ASTS Council viewpoint.
- 2202 kidney transplant recipients with 10 years of graft function: what happens next?
- Earlier is not necessarily better in preemptive kidney transplantation.
- In defense of a regulated system of compensation for living donation.
- Posttransplant diabetes mellitus and acute rejection: impact on kidney transplant outcome.
- Resolved: in minimizing kidney transplant immunosuppression, steroids should go before calcineurin inhibitors: pro.
- Cystatin C is not superior to creatinine-based models in estimating glomerular filtration rate in former kidney donors.
- Stable kidney function in the second decade after kidney transplantation while on cyclosporine-based immunosuppression.
- Steroid-free immunosuppression in kidney transplant recipients: the University of Minnesota experience.
- Why we should develop a regulated system of kidney sales: a call for action!
- Urinary beta2-microglobulin is associated with acute renal allograft rejection.
- Transplantation using marginal living donors.
- Persistent, asymptomatic, microscopic hematuria in prospective kidney donors.
- Surgical complications after kidney transplantation.
- The importance of innovative efforts to increase organ donation.
- Rapid discontinuation of prednisone in higher-risk kidney transplant recipients.
- Long-term immunosuppression, without maintenance prednisone, after kidney transplantation.
- Plasma homocysteine levels in living kidney donors before and after uninephrectomy.
- Medication noncompliance: another iceberg's tip.
- Determinants of quality of life changes among long-term cardiac transplant survivors: results from longitudinal data.
- Predicting long-term kidney graft survival: can new trials be performed?
- Positive remote crossmatch: impact on short-term and long-term outcome in cadaver renal transplantation.
- Why study kidney transplant risk factors?
- Evolution of a nondirected kidney donor program: lessons learned.
- The nondirected live-kidney donor: ethical considerations and practice guidelines: A National Conference Report.
- Five preventable causes of kidney graft loss in the 1990s: a single-center Analysis.
- Predictors of renal function following lung or heart-lung transplantation.
- Preemptive kidney transplantation: the advantage and the advantaged.
- Proposed guidelines for re-evaluation of patients on the waiting list for renal cadaver transplantation.
- Cystatin C enhances glomerular filtration rate estimating equations in kidney transplant recipients.
Schools
University Of Manitoba Faculty Of Medicine
University Of Minnesota
Procedures Preformed
- Embolectomy, Thrombectomy, or Vessel Exploration
- Lymph Node Biopsy or Excision
Conditions Treated
- Anal and Rectal Cancer
- Breast Lump
- Colorectal Cancer
- Crohn's Disease (Regional Enteritis)
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
University of Minnesota at Fairview -
University of Manitoba
Hospital
-
University of Minnesota Medical Center, Fairview
Drug Facts
| NPI NUMBER | 1306920657 | |
| NPPES Provider LastName | MATAS | |
| NPPES Provider FirstName | ARTHUR | |
| NPPES Provider ZIPCode | 55455 | |
| NPPES Provider State | MN | |
| Specialty Description | General Surgery | |
| Total Claim Count | 1873.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1306920657 |
| Last Name Of The Provider | MATAS |
| First Name Of The Provider | ARTHUR |
| View All |
Similar Doctors
|
|
Dr. Jonathan C. Papic, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jesse M. Manunga Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William Leon, MD |
|
|
Dr. William D. Payne, MD |
|
Dr. Charles O. Finne III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark D. Odland, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Diane K. Stoller, MD |
|
|
Dr. Elliot G. Arsoniadis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Luke T. Hawes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jean D. Morancy, MD |